Estimaciones de analistas de Wall Street para Krystal Biotech, Inc. (KRYS): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-02 | $1.91 | ||
| 2026-08-03 | $1.79 | $1.70 | +5.3% |
| 2026-05-04 | $1.83 | $1.45 | +26.2% |
| 2026-02-17 | $1.70 | $1.62 | +4.9% |
| 2025-11-03 | $2.66 | $1.12 | +137.5% |
| 2025-08-04 | $1.29 | $1.08 | +19.4% |
| 2025-05-06 | $1.20 | $1.38 | -13.0% |
| 2025-02-19 | $1.52 | $1.29 | +17.8% |
Ratios de valoración
| Ratio P/E | 39.88 |
| Precio / Valor contable | 7.17 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | $1.0M | 0 | 0 | 0 | 0 | $50.7M | $290.5M | $389.1M |
| Coste de Ventas | $2000 | $23000 | $141000 | $974000 | $1.9M | 0 | 0 | $3.1M | $20.1M | $28.8M |
| Beneficio Bruto | -$2000 | -$23000 | $886000 | -$974000 | -$1.9M | 0 | 0 | $47.6M | $270.5M | $360.4M |
| I+D | $741000 | $3.2M | $7.8M | $15.6M | $17.9M | $27.9M | $42.5M | $46.4M | $53.6M | $58.0M |
| Generales y Administrativos | $402000 | $1.6M | $4.2M | $6.5M | $13.2M | $40.4M | $77.7M | $98.4M | $113.7M | $146.7M |
| Gastos Operativos | $1.1M | $4.8M | $11.9M | $22.1M | $31.1M | $68.3M | $145.2M | $157.3M | $204.8M | $199.1M |
| Beneficio Operativo | -$1.1M | -$4.8M | -$11.9M | -$22.1M | -$33.0M | -$68.3M | -$145.2M | -$109.7M | $65.7M | $161.3M |
| EBITDA | -$1.1M | -$4.6M | -$10.7M | -$18.1M | -$30.3M | -$66.2M | -$116.8M | -$91.3M | $109.9M | $196.0M |
| Gastos por Intereses | $7000 | $3.1M | $1.0M | 0 | 0 | $1.5M | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$1.1M | -$7.9M | -$10.9M | -$19.1M | -$32.2M | -$69.6M | -$140.0M | $12.9M | $95.4M | $189.5M |
| Impuestos | 0 | 0 | -$20141 | 0 | 0 | 0 | 0 | $2.0M | $6.2M | -$15.4M |
| Beneficio Neto | -$1.1M | -$7.9M | -$10.9M | -$19.1M | -$32.2M | -$69.6M | -$140.0M | $10.9M | $89.2M | $204.8M |
| BPA | $-0.27 | $-1.48 | $-0.97 | $-1.20 | $-1.71 | $-3.13 | $-5.49 | $0.40 | $3.12 | $7.08 |
| BPA Diluido | $-0.27 | $-1.48 | $-0.97 | $-1.20 | $-1.71 | $-3.13 | $-5.49 | $0.39 | $3.00 | $6.84 |
| Acciones en Circulación (Diluidas) | $4.3M | $5.4M | $11.2M | $15.9M | $18.8M | $22.2M | $25.5M | $27.8M | $29.7M | $30.0M |
Precio
| Precio | $337.83 |
| Capitalización | $10.0B |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ACLX · ALKS · ARWR · CRSP · MTSR · PCVX · PTCT
Explorar sector: Healthcare · Biotechnology
Más secciones de KRYS: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones